Cargando…
Extracellular Vesicles in Inner Ear Therapies—Pathophysiological, Manufacturing, and Clinical Considerations
(1) Background: Sensorineural hearing loss is a common and debilitating condition. To date, comprehensive pharmacologic interventions are not available. The complex and diverse molecular pathology that underlies hearing loss may limit our ability to intervene with small molecules. The current review...
Autores principales: | Warnecke, Athanasia, Staecker, Hinrich, Rohde, Eva, Gimona, Mario, Giesemann, Anja, Szczepek, Agnieszka J., Di Stadio, Arianna, Hochmair, Ingeborg, Lenarz, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788356/ https://www.ncbi.nlm.nih.gov/pubmed/36556073 http://dx.doi.org/10.3390/jcm11247455 |
Ejemplares similares
-
A Window of Opportunity: Perilymph Sampling from the Round Window Membrane Can Advance Inner Ear Diagnostics and Therapeutics
por: Peter, Madeleine St., et al.
Publicado: (2022) -
Improving Control of Gene Therapy-Based Neurotrophin Delivery for Inner Ear Applications
por: St. Peter, Madeleine, et al.
Publicado: (2022) -
Neuroinflammatory disorders of the brain and inner ear: a systematic review of auditory function in patients with migraine, multiple sclerosis, and neurodegeneration to support the idea of an innovative ‘window of discovery’
por: Di Stadio, Arianna, et al.
Publicado: (2023) -
First‐in‐human intracochlear application of human stromal cell‐derived extracellular vesicles
por: Warnecke, Athanasia, et al.
Publicado: (2021) -
A potential serological biomarker for inner ear pathologies: OTOLIN-1
por: Avallone, Emilio, et al.
Publicado: (2022)